SECsense Logo

Quoin Pharmaceuticals Ltd. 8-K Report: Key Insights on Recent Corporate Events

$QNRX
Form 8-K
Filed on: 2024-12-26
Source
Quoin Pharmaceuticals Ltd. 8-K Report: Key Insights on Recent Corporate Events

Based on the provided section of the financial report, here are the key insights extracted:

  1. Entity Identification:
  • Company Name: Quoin Pharmaceuticals Ltd.
  • SEC CIK Number: 0001671502
  • Reporting Type: Form 8-K (a current report filed with the SEC for major events that shareholders should know about).
  1. Location:
  • Address: 42127 Pleasant Forest Court, Ashburn, VA 20148-7349, USA
  • Phone Number: 703-980-4182
  1. Financial Reporting Period:
  • Report Date: December 20, 2024
  • Period End Date: December 20, 2024 (indicating this report may cover a specific event on this date).
  1. Securities Information:
  • Type of Securities: American Depositary Shares (ADS), each representing one Ordinary Share with no par value.
  • Trading Symbol: QNRX
  • Exchange: NASDAQ
  1. Currency and Units:
  • Currency: USD (United States Dollar)
  • Units of Measurement: Shares and USD per shares.
  1. Additional Notes:
  • The filing does not contain any specific financial figures or operational updates in this snippet, but the context suggests it may involve significant corporate events or transactions relevant to stakeholders.

This analysis highlights the necessary identifiers and context for Quoin Pharmaceuticals Ltd. as of the specified report date, reflecting both corporate identity and securities information relevant to investors and analysts. Further details would be needed for a comprehensive financial analysis.